Newmont Derivative Gain (Loss) Excluded from Effectiveness decreased by 18.2% to -$39.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 50.6%, from -$79.00M to -$39.00M. Over 4 years (FY 2021 to FY 2025), Derivative Gain (Loss) Excluded from Effectiveness shows an upward trend with a -4.4% CAGR.
abbv_derivative_gain_loss_excluded_from_effectiveness| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$68.00M | -$66.00M | -$66.00M | -$62.00M | -$57.00M | -$55.00M | -$53.00M | -$65.00M | -$49.00M | -$48.00M | -$81.00M | -$93.00M | -$103.00M | -$86.00M | -$93.00M | -$79.00M | -$65.00M | -$52.00M | -$33.00M | -$39.00M |
| QoQ Change | — | +2.9% | +0.0% | +6.1% | +8.1% | +3.5% | +3.6% | -22.6% | +24.6% | +2.0% | -68.8% | -14.8% | -10.8% | +16.5% | -8.1% | +15.1% | +17.7% | +20.0% | +36.5% | -18.2% |
| YoY Change | — | — | — | — | +16.2% | +16.7% | +19.7% | -4.8% | +14.0% | +12.7% | -52.8% | -43.1% | -110.2% | -79.2% | -14.8% | +15.1% | +36.9% | +39.5% | +64.5% | +50.6% |